Results hosted on duckduckgo.com
Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses.
Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.
Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs in Europe, although HCV infection is both preventable and curable. Effective interventions that target the prevention of HCV transmission and the treatment of hepatitis C are needed, particularly for so-called ‘hard to reach’ and vulnerable populations.
People who inject drugs are a key population for the elimination of hepatitis C in Europe; increasing access to HCV testing and care for this group is a goal in European and national hepatitis C policies. This EMCDDA Harm Reduction initiative provides a set of new materials and tools to help countries to analyse barriers to testing at drug services, to identify solutions in collaboration with all stakeholders involved and to implement new models of care in this field.
Learn morePublications by the EMCDDA on this topic
EMCDDA activities, services and tools on this topic
Photos, infographics and videos from our Media library
